Cargando…
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell–Depleted Stem Cell Transplantation
Covid-19 vaccination is recommended in allogeneic transplant recipients, but many questions remain regarding its efficacy. Here we studied serologic responses in 145 patients who had undergone allogeneic transplantation using in vivo T-cell depletion. Median age was 57 (range 21-79) at transplantati...
Autores principales: | Chaekal, Ok-kyong, Gomez-Arteaga, Alexandra, Chen, Zhengming, Soave, Rosemary, Shore, Tsiporah, Mayer, Sebastian, Phillips, Adrienne, Hsu, Jing Mei, Drelick, Alexander, Kodiyanplakkal, Rosy Priya L., Plate, Markus, Satlin, Michael J., van Besien, Koen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213029/ https://www.ncbi.nlm.nih.gov/pubmed/35724850 http://dx.doi.org/10.1016/j.jtct.2022.06.012 |
Ejemplares similares
-
2695. Pneumocystis jirovecii Pneumonia in the Era of Effective Prophylaxis Following Hematopoietic Stem Cell Transplant
por: Drelick, Alexander Christian, et al.
Publicado: (2019) -
532. COVID-19 Pneumonia in Patients with Hematologic Malignancies – A Report from the US Epicenter
por: Plate, Markus, et al.
Publicado: (2020) -
Coronavirus Infection in Hematopoietic Stem Cell Transplant Recipients
por: Eichenberger, Emily, et al.
Publicado: (2017) -
2501. Impact of Influenza A and B Infection on Stem Cell Transplant Patients During the 2017–2018 Season at a Single Center
por: Pyai, Khin Sandar, et al.
Publicado: (2018) -
Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients
por: Eichenberger, Emily M., et al.
Publicado: (2018)